Zimmer Biomet Holdings, Inc. (ZBH)
What changed in recent filings
- Institutions — 8 new · 2 added13F · as of end of 2026 Q2
What changed in recent SEC filings — factual, not a buy/sell recommendation.
Institutions holding Zimmer Biomet Holdings, Inc.
How many of the institutions we track reported holding this stock, quarter by quarter.
2019 Q1: 2 → 2026 Q2: 10 institutions
Counts the 52 institutions we track that reported holding this stock — their full reported holdings, not just the largest positions. Not the total number of institutional holders in the US. Figures are as of quarter-end and disclosed up to 45 days later. Descriptive only — not investment advice.
Which institutions hold Zimmer Biomet Holdings, Inc.
Institutions we track that reported holding this stock in their most recent 13F.
- Bridgewater Associates0.01% of portfolio · since 2020 Q3
- Dodge & Cox1.09% of portfolio · since 2022 Q1
- Tudor Investment CorpNew this quarter0.01% of portfolio · since 2026 Q2
- Point72 Asset ManagementNew this quarter0.08% of portfolio · since 2026 Q2
- Moore Capital ManagementNew this quarter0.25% of portfolio · since 2026 Q2
- PRIMECAP Management0.19% of portfolio · held as of 2026 Q2 or earlier
- Blackstoneunder 0.01% of portfolio · held as of 2026 Q2 or earlier
- National Pension Service (Korea)0.01% of portfolio · held as of 2026 Q2 or earlier
- Harris Associates (Oakmark)1.45% of portfolio · held as of 2026 Q2 or earlier
- Capital World Investorsunder 0.01% of portfolio · held as of 2026 Q2 or earlier
Based on 13F filings — quarter-end holdings, disclosed up to 45 days later. Holding a stock is a fact we report, not a recommendation to buy or sell.
Company overview
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
What is the Biotech & Health sector?
Pharma, biotech, and medical devices. Driven by trial-result events.
Zimmer Biomet Holdings, Inc. is classified under the Biotech & Health sector. See peers below.
ETFs holding Zimmer Biomet Holdings, Inc.
Per SEC N-PORT · 2026-06-30 · by weight · factual
ZBH on Stocklore
- Revenue by segment — segment weights verified from SEC filings, YoY changes, growth drivers and concentration
- Financials & earnings quality — 6 metrics (FCF conversion, ROIC, net debt, etc.) to gauge profit quality
- 13F institutional holdings — holdings and weight changes of major institutions (45-day delay)
- Sector-relative metrics — Valuation and growth compared with the Biotech & Health average
Peers · Biotech & Health
ZBH FAQ
What is Zimmer Biomet Holdings, Inc. (ZBH)?
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
What sector is Zimmer Biomet Holdings, Inc. in?
Zimmer Biomet Holdings, Inc. is classified under Biotech & Health. Pharma, biotech, and medical devices. Driven by trial-result events.
Where can I analyze Zimmer Biomet Holdings, Inc. (ZBH) stock?
On Stocklore you can see ZBH's financials & earnings quality, 13F institutional holdings, and sector-relative metrics in one place. This page is for information and tools — not a buy/sell recommendation.
Data sources: SEC EDGAR (financials & filings), 13F (institutional holdings, as of quarter-end), market data. This page is for information and analysis tools — it does not recommend buying or selling any security. Investment decisions and responsibility are your own.